First Interstate Bank Sells 1,059 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

First Interstate Bank lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 42,428 shares of the financial services provider’s stock after selling 1,059 shares during the period. First Interstate Bank owned approximately 0.08% of iShares Biotechnology ETF worth $5,764,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Glass Jacobson Investment Advisors llc boosted its holdings in iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 122 shares during the last quarter. PCA Investment Advisory Services Inc. purchased a new stake in iShares Biotechnology ETF in the second quarter worth approximately $28,000. Values First Advisors Inc. purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth approximately $43,000. Tennessee Valley Asset Management Partners purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth approximately $44,000. Finally, Horizon Bancorp Inc. IN purchased a new stake in iShares Biotechnology ETF in the third quarter worth approximately $44,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.7 %

Shares of iShares Biotechnology ETF stock traded down $0.87 on Tuesday, hitting $126.97. 1,753,613 shares of the company’s stock were exchanged, compared to its average volume of 1,808,489. The company has a 50-day simple moving average of $135.63 and a 200-day simple moving average of $129.57. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date of this dividend was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.